Interview Details - Overview
Expert Interviews in Lung Cancer: Optimizing Current Approaches to the Treatment of NSCLC
Release Date: March 5, 2009|
Expiration Date: March 5, 2010
Mar 5, 2009, Expert Interviews
Lecture Overview
For decades, little progress was observed in the treatment of advanced non–small-cell lung cancer (NSCLC). More recently, the development of improved chemotherapeutic agents and targeted agents has provided effective treatment choices. Additionally, new approaches to administering chemotherapy, including maintenance following completion of a frontline doublet, have the potential to prolong responses and survival in patients with advanced NSCLC.
The purpose of this activity is to inform physicians of novel cytotoxic and targeted approaches to the treatment of lung cancer.
This educational activity is intended for medical oncologists involved in the care of patients with lung cancer. No specific skills or knowledge other than a basic training in oncology is required for successful participation in this activity.
Upon completion of this educational activity, you should be able to:
- Discuss the efficacy and safety of maintenance chemotherapy following a frontline doublet in metastatic NSCLC
- Assess the efficacy and adverse event profile of frontline epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced NSCLC
- Describe clinical data on antiangiogenic agents used with various chemotherapy backbones in metastatic NSCLC
Instructions for Participation
- Read the following information before entering the educational activity.
- Complete the Pretest.
- View and study Flash video presentation and slides.
- Complete the Posttest.
- Answer the evaluation questions.
- After completion of the Pretest and successful completion of the Posttest and evaluation, you will receive your certificate online.
- You will be permitted 2 attempts to successfully complete the Posttest.
You will be asked to login
or create an account.